PRLD — Prolight Diagnostics AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK60.00m
- SEK46.73m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.25 | ||
| Price to Tang. Book | 3.97 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -11.67% | ||
| Return on Equity | -12.44% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Prolight Diagnostics AB (publ) is a Sweden-based medical technology company. Together with Technology Partners, the Company develops patient-close test systems based on patented technology, for use in so-called Point of Care Testing (POCT). POCT tests are performed outside the traditional hospital laboratory, small mobile instruments enable testing near the patient and provide quick test answers. The Company focuses on the heart marker troponin.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- May 18th, 1999
- Public Since
- March 31st, 2017
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Nordic Growth Market - Stockholm
- Shares in Issue
- 346,822,966
- Address
- Gasverksgatan 1, 4 tr, LUND, 222 29
- Web
- https://www.prolightdiagnostics.se/
- Phone
- +46 46162065
- Auditors
- Mazars AB
Upcoming Events for PRLD
Prolight Diagnostics AB (publ) Annual Shareholders Meeting
Similar to PRLD
ATTANA AB
Nordic Growth Market - Stockholm
Coegin Pharma AB
Nordic Growth Market - Stockholm
Lumito AB (publ)
Nordic Growth Market - Stockholm
Lumito AB (publ)
Nordic Growth Market - Stockholm
FAQ
What is the Prolight Diagnostics AB (publ) share price?
As of Today at 19:17 UTC, shares in Prolight Diagnostics AB (publ) are trading at SEK0.17. This share price information is delayed by 15 minutes.
How has the Prolight Diagnostics AB (publ) share price performed this year?
Shares in Prolight Diagnostics AB (publ) last closed at SEK0.17 and the price had moved by -45.08% over the past 365 days. In terms of relative price strength the Prolight Diagnostics AB (publ) share price has underperformed the FTSE Global All Cap Index by -49.34% over the past year.
What are the analyst and broker recommendations for Prolight Diagnostics AB (publ)?
There is no consensus recommendation for this security.
What is the Prolight Diagnostics AB (publ) dividend yield?
Prolight Diagnostics AB (publ) does not currently pay a dividend.
Does Prolight Diagnostics AB (publ) pay a dividend?
Prolight Diagnostics AB (publ) does not currently pay a dividend.
When does Prolight Diagnostics AB (publ) next pay dividends?
Prolight Diagnostics AB (publ) does not currently pay a dividend.
How do I buy Prolight Diagnostics AB (publ) shares?
To buy shares in Prolight Diagnostics AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Prolight Diagnostics AB (publ)?
As of the previous close price of SEK0.17, shares in Prolight Diagnostics AB (publ) had a market capitalisation of SEK60.00m.
Where are Prolight Diagnostics AB (publ) shares listed?
Here are the trading details for Prolight Diagnostics AB (publ):
- Country of listing: Sweden
- Exchange: NGM
- Ticker Symbol: PRLD
What kind of share is Prolight Diagnostics AB (publ)?
Based on an overall assessment of its quality, value and momentum Prolight Diagnostics AB (publ) is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Prolight Diagnostics AB (publ) share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Prolight Diagnostics AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Prolight Diagnostics AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -78.71%.
As of the last closing price of SEK0.17, shares in Prolight Diagnostics AB (publ) were trading -67.91% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Prolight Diagnostics AB (publ) PE Ratio?
The Prolight Diagnostics AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.17.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Prolight Diagnostics AB (publ)?
We do not have data on Prolight Diagnostics AB (publ)'s directors